BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 16246058)

  • 1. Studies of the aggregation of an amyloidogenic alpha-synuclein peptide fragment.
    Madine J; Doig AJ; Kitmitto A; Middleton DA
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1113-5. PubMed ID: 16246058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assembly of alpha-synuclein fibrils in nanoscale studied by peptide truncation and AFM.
    Zhang F; Lin XJ; Ji LN; Du HN; Tang L; He JH; Hu J; Hu HY
    Biochem Biophys Res Commun; 2008 Apr; 368(2):388-94. PubMed ID: 18230346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceleration of alpha-synuclein aggregation by homologous peptides.
    Du HN; Li HT; Zhang F; Lin XJ; Shi JH; Shi YH; Ji LN; Hu J; Lin DH; Hu HY
    FEBS Lett; 2006 Jun; 580(15):3657-64. PubMed ID: 16764865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review: formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins.
    El-Agnaf OM; Irvine GB
    J Struct Biol; 2000 Jun; 130(2-3):300-9. PubMed ID: 10940234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chaperone activity of α-synuclein: Utilizing deletion mutants to map its interaction with target proteins.
    Rekas A; Ahn KJ; Kim J; Carver JA
    Proteins; 2012 May; 80(5):1316-25. PubMed ID: 22274962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of different regions of alpha-synuclein in the assembly of fibrils.
    Qin Z; Hu D; Han S; Hong DP; Fink AL
    Biochemistry; 2007 Nov; 46(46):13322-30. PubMed ID: 17963364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine and the dopamine oxidation product 5,6-dihydroxylindole promote distinct on-pathway and off-pathway aggregation of alpha-synuclein in a pH-dependent manner.
    Pham CL; Leong SL; Ali FE; Kenche VB; Hill AF; Gras SL; Barnham KJ; Cappai R
    J Mol Biol; 2009 Apr; 387(3):771-85. PubMed ID: 19361420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein interactions and misfolding analyzed by AFM force spectroscopy.
    McAllister C; Karymov MA; Kawano Y; Lushnikov AY; Mikheikin A; Uversky VN; Lyubchenko YL
    J Mol Biol; 2005 Dec; 354(5):1028-42. PubMed ID: 16290901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation.
    Liu IH; Uversky VN; Munishkina LA; Fink AL; Halfter W; Cole GJ
    Glycobiology; 2005 Dec; 15(12):1320-31. PubMed ID: 16037493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The conformation and the aggregation kinetics of α-synuclein depend on the proline residues in its C-terminal region.
    Meuvis J; Gerard M; Desender L; Baekelandt V; Engelborghs Y
    Biochemistry; 2010 Nov; 49(43):9345-52. PubMed ID: 20828147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational properties of the SDS-bound state of alpha-synuclein probed by limited proteolysis: unexpected rigidity of the acidic C-terminal tail.
    de Laureto PP; Tosatto L; Frare E; Marin O; Uversky VN; Fontana A
    Biochemistry; 2006 Sep; 45(38):11523-31. PubMed ID: 16981712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The aggregation and membrane-binding properties of an alpha-synuclein peptide fragment.
    Madine J; Doig AJ; Middleton DA
    Biochem Soc Trans; 2004 Dec; 32(Pt 6):1127-9. PubMed ID: 15506987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-synuclein aggregation variable temperature and variable pH kinetic data: a re-analysis using the Finke-Watzky 2-step model of nucleation and autocatalytic growth.
    Morris AM; Finke RG
    Biophys Chem; 2009 Mar; 140(1-3):9-15. PubMed ID: 19101068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation.
    Uversky VN
    J Neurochem; 2007 Oct; 103(1):17-37. PubMed ID: 17623039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tilted properties of the 67-78 fragment of alpha-synuclein are responsible for membrane destabilization and neurotoxicity.
    Crowet JM; Lins L; Dupiereux I; Elmoualija B; Lorin A; Charloteaux B; Stroobant V; Heinen E; Brasseur R
    Proteins; 2007 Sep; 68(4):936-47. PubMed ID: 17554782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards multiparametric fluorescent imaging of amyloid formation: studies of a YFP model of alpha-synuclein aggregation.
    van Ham TJ; Esposito A; Kumita JR; Hsu ST; Kaminski Schierle GS; Kaminski CF; Dobson CM; Nollen EA; Bertoncini CW
    J Mol Biol; 2010 Jan; 395(3):627-42. PubMed ID: 19891973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of fibril formation and toxicity of a fragment of alpha-synuclein by an N-methylated peptide analogue.
    Bodles AM; El-Agnaf OM; Greer B; Guthrie DJ; Irvine GB
    Neurosci Lett; 2004 Apr; 359(1-2):89-93. PubMed ID: 15050719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the core structure of lysozyme amyloid fibrils by proteolysis.
    Frare E; Mossuto MF; Polverino de Laureto P; Dumoulin M; Dobson CM; Fontana A
    J Mol Biol; 2006 Aug; 361(3):551-61. PubMed ID: 16859705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linker histone H1 binds to disease associated amyloid-like fibrils.
    Duce JA; Smith DP; Blake RE; Crouch PJ; Li QX; Masters CL; Trounce IA
    J Mol Biol; 2006 Aug; 361(3):493-505. PubMed ID: 16854430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.